Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen + Caffeine vs Ibuprofen for Migraine
NCT01426971Phase 3Withdrawn
- Sponsor
- Sanofi
- Start
- Dec 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of caffeine in migraine, sponsored by Sanofi. Planned start Dec 2012; status: withdrawn.
02
Drugs
caffeine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01426971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01426971.